Patent details

Basic Information

Publication number:

EP2668181

PCT Application Number:

PCT/EP/2012/050830

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127006955

PCT Publication Number:

WO/2012/101043

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS

French Title of Invention:

COMPOSÉS DE PYRAZOLE EN TANT QU'ANTAGONISTES DE CRTH2

German Title of Invention:

PYRAZOLVERBINDUNGEN ALS CRTH2-ANTAGONISTEN

SPC Number:

Dates

Filing date:

20/01/2012

Grant date:

05/11/2014

EP Publication Date:

05/11/2014

PCT Publication Date:

02/08/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/12/2013

EP B1 Publication Date:

05/11/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/01/2022

Expiration date:

20/01/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/07/2019

 

 

Name:

GB001, Inc.

Address:

3013 Science Park Road, Suite 200, San Diego, CA 92121, United States (US)

History of Owners

From:

31/07/2019

To:

31/07/2019

Name:

Actimis Pharmaceuticals, Inc.

Address:

c/o Sanderling Ventures, 400 S. El Camino Real, Suite 1200, San Mateo, CA 94402, United States (US)

From:

20/01/2012

To:

31/07/2019

Name:

Boehringer Ingelheim International GmbH

Address:

Binger Straße 173, 55216 Ingelheim, Germany (DE)

Inventor

1

Name:

OOST Thorsten

Address:

Germany (DE)

2

Name:

SEITHER Peter

Address:

Germany (DE)

3

Name:

ANDERSKEWITZ Ralf

Address:

Germany (DE)

4

Name:

RIST Wolfgang

Address:

Germany (DE)

5

Name:

MARTYRES Domnic

Address:

Germany (DE)

Priority

Priority Number:

11151876

Priority Date:

24/01/2011

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07D 403/12;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2019/10

Publication date:

23/09/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2019/10

Publication date:

23/09/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000291A

Date Registered:

31/07/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Actimis Pharmaceuticals, Inc.

Address:

c/o Sanderling Ventures, 400 S. El Camino Real, Suite 1200, San Mateo, CA 94402, United States (US)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000292A

Date Registered:

31/07/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

GB001, Inc.

Address:

3013 Science Park Road, Suite 200, San Diego, CA 92121, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

19/07/2021

Last Annual Fee Paid Number:

10

Last Annual Fee Paid Amount:

131 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
31/07/2019	Request For Change	7
05/08/2019	Outgoing Correspondence	1
31/07/2019	Request For Change	10
05/08/2019	Outgoing Correspondence	1